Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponatinib with chemotherapy in young adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
2015-004202-41Phase 2Active
- Sponsor
- Fundación PETHEMA
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ponatinib in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Primary endpoints: Complete hematologic response, Complete cytogenetic response and 10 more. Started Feb 2016; status: active.
02
Drugs
ponatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2015-004202-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004202-41.